Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended June 30, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-41082

FTAC ZEUS ACQUISITION CORP.

(Exact Name of Registrant as Specified in Its Charter)

Delaware		85-4260524
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

2929 Arch Street, Suite 1703, Philadelphia, PA 19104

(Address of principal executive offices) (Zip Code)

(215) 701-9555

(Issuer’s telephone number)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A common stock, par value $0.0001 per share	ZING	Nasdaq Global Market
Warrants, each whole warrant exercisable for one share of Class A common stock	ZINGW	Nasdaq Global Market
Units, each consisting of one share of Class A common stock and one- half of one redeemable warrant	ZINGU	Nasdaq Global Market

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of August 10, 2023, there were 42,028,750 shares of Class A common stock, $0.0001 par value and 14,009,583 shares of Class B common stock, $0.0001 par value, issued and outstanding.

FTAC ZEUS ACQUISITION CORP.

FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2023

TABLE OF CONTENTS

		Page
Part I. Financial Information		1
Item 1. Interim Financial Statements		1
Condensed Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022		1
Unaudited Condensed Statements of Operations for the Three and Six Months Ended June 30, 2023 and 2022		2
Unaudited Condensed Statements of Changes in Stockholders’ Deficit for the Three and Six Months Ended June 30, 2023 and 2022		3
Unaudited Condensed Statements of Cash Flows for the Six Months Ended June 30, 2023 and 2022		4
Notes to Condensed Financial Statements (Unaudited)		5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		17
Item 3. Quantitative and Qualitative Disclosures About Market Risk		22
Item 4. Controls and Procedures		22
Part II. Other Information
Item 1. Legal Proceedings		23
Item 1A. Risk Factors		23
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		23
Item 3. Defaults Upon Senior Securities		23
Item 4. Mine Safety Disclosures		23
Item 5. Other Information		23
Item 6. Exhibits		24
Part III. Signatures		25

PART I - FINANCIAL INFORMATION

Item 1. Interim Financial Statements.

FTAC ZEUS ACQUISITION CORP.

CONDENSED BALANCE SHEETS

	June 30, 2023			December 31, 2022
		(Unaudited)
Assets
Current assets
Cash	$	213,035		$	557,193
Prepaid expenses		52,376			9,499
Total Current Assets		265,411			566,692

Reimbursement receivable		6,860,000			6,860,000
Investments held in Trust Account		420,376,676			413,569,723
Total Assets	$	427,502,087		$	420,996,415

Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit
Current liabilities
Accounts payable and accrued expenses	$	299,041		$	236,574
Income taxes payable		30,229			553,444
Due to related party		21,935			21,935
Promissory note – related party		750,000			—
Total current liabilities		1,101,205			811,953

Deferred underwriting fee payable		17,150,000			17,150,000
Deferred advisory fees		6,860,000			6,860,000
Total liabilities		25,111,205			24,821,953

Commitments and Contingencies

Class A common stock subject to possible redemption, $0.0001 par value; 40,250,000 issued and outstanding shares at a redemption value of $10.44 and $10.26 per share as of June 30, 2023 and December 31, 2022, respectively		420,326,449			412,836,569

Stockholders’ Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of June 30, 2023 and December 31, 2022		—			—
Class A common stock, $0.0001 par value; 90,000,000 shares authorized; 1,778,750 shares issued and outstanding (excluding 40,250,000 shares subject to possible redemption) as of June 30, 2023 and December 31, 2022		178			178
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 14,009,583 shares issued and outstanding as of June 30, 2023 and December 31, 2022		1,401			1,401
Accumulated deficit		(17,937,146	)		(16,663,686	)
Total Stockholders’ Deficit		(17,935,567	)		(16,662,107	)
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit	$	427,502,087		$	420,996,415

The accompanying notes are an integral part of the unaudited condensed financial statements.

FTAC ZEUS ACQUISITION CORP.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

	Three Months Ended June 30,						Six Months Ended June 30,
	2023			2022			2023			2022
Formation and operating costs	$	584,730		$	893,496		$	1,195,915		$	1,677,979
Loss from operations		(584,730	)		(893,496	)		(1,195,915	)		(1,677,979	)

Other income:
Interest income earned on investments held in trust account		4,967,960			551,634			9,356,120			592,774
Total other income, net		4,967,960			551,634			9,356,120			592,774

Income (Loss) before provision for income taxes		4,383,230			(341,862	)		8,160,205			(1,085,205	)
Provision for income taxes		(1,032,771	)		(102,084	)		(1,943,785	)		(102,084	)
Net income (loss)	$	3,350,459		$	(443,946	)	$	6,216,420		$	(1,187,289	)

Basic and diluted weighted average shares outstanding, Class A common stock		42,028,750			42,028,750			42,028,750			42,028,750
Basic and diluted net income (loss) per common stock, Class A common stock	$	0.06		$	(0.01	)	$	0.11		$	(0.02	)
Basic and diluted weighted average shares outstanding, Class B common stock		14,009,583			14,009,583			14,009,583			14,009,583
Basic and diluted net income (loss) per common stock, Class B common stock	$	0.06		$	(0.01	)	$	0.11		$	(0.02	)

The accompanying notes are an integral part of the unaudited condensed financial statements.

FTAC ZEUS ACQUISITION CORP.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023

	Class A				Class B				Additional					Total
	Common Stock				Common Stock				Paid-in		Accumulated			Stockholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balance as of January 1, 2023		1,778,750	$	178		14,009,583	$	1,401	$	—	$	(16,663,686	)	$	(16,662,107	)
Accretion of Class A common stock subject to possible redemption		—		—		—		—		—		(3,654,690	)		(3,654,690	)
Net income		—		—		—		—		—		2,865,961			2,865,961
Balance as of March 31, 2023 (unaudited)		1,778,750	$	178		14,009,583	$	1,401	$	—	$	(17,452,415	)	$	(17,450,836	)
Accretion of Class A common stock subject to possible redemption		—		—		—		—		—		(3,835,190	)		(3,835,190	)
Net income		—		—		—		—		—		3,350,459			3,350,459
Balance as of June 30, 2023 (unaudited)		1,778,750	$	178		14,009,583	$	1,401	$	—	$	(17,937,146	)	$	(17,935,567	)

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022

	Class A				Class B				Additional					Total
	Common Stock				Common Stock				Paid-in		Accumulated			Stockholder’
	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balance as of January 1, 2022		1,778,750	$	178		14,009,583	$	1,401	$	—	$	(13,743,025	)	$	(13,741,446	)
Net loss		—		—		—		—		—		(743,343	)		(743,343	)
Balance as of March 31, 2022 (unaudited)		1,778,750		178		14,009,583		1,401		—		(14,486,368	)		(14,484,789	)
Accretion of Class A common stock subject to possible redemption		—		—		—		—		—		(347,669	)		(347,669	)
Net loss		—		—		—		—		—		(443,946	)		(443,946	)
Balance as of June 30, 2022 (unaudited)		1,778,750	$	178		14,009,583	$	1,401	$	—	$	(15,277,983	)	$	(15,276,404	)

The accompanying notes are an integral part of the unaudited condensed financial statements.

FTAC ZEUS ACQUISITION CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	For the Six Months Ended June 30,
	2023			2022
Cash Flows from Operating Activities:
Net income (loss)	$	6,216,420		$	(1,187,289	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest income earned on investments held in trust account		(9,356,120	)		(592,774	)
Changes in operating assets and liabilities:
Prepaid expenses		(42,877	)		(82,821	)
Income taxes payable		(523,215	)		102,084
Accounts payable and accrued expenses		62,467			84,678
Net cash used in operating activities		(3,643,325	)		(1,676,122	)

Cash Flows from Investing Activities:
Cash withdrawn from Trust Account for tax purposes		2,549,167			35,733
Net cash provided by investing activities		2,549,167			35,733

Cash Flows from Financing Activities:
Proceeds from promissory note – related party		750,000			—
Repayment of advances from related party		—			(445	)
Net cash provided by (used in) financing activities		750,000			(445	)

Net Change in Cash		(344,158	)		(1,640,834	)
Cash – Beginning of period		557,193			3,474,184
Cash – End of period	$	213,035		$	1,833,350

Supplementary cash flow information:
Cash paid for income taxes	$	2,467,000		$	—

The accompanying notes are an integral part of the unaudited condensed financial statements.

FTAC ZEUS ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

NOTE 1. ORGANIZATION AND BUSINESS OPERATIONS

FTAC Zeus Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on December 11, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

All activity for the period from December 11, 2020 (inception) through December 31, 2020 was de minimis and related only to the Company’s formation. All activity for the period from January 1, 2021 (commencement of operations) through June 30, 2023 relates to the Company’s formation, Initial Public Offering (as defined below), and efforts in identifying a target to consummate an initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering placed in the Trust Account (as defined below).

The registration statements for the Company’s Initial Public Offering were declared effective on November 18, 2021. On November 23, 2021, the Company consummated the Initial Public Offering of 40,250,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriter of its over-allotment option in the amount of 5,250,000 Units, at $10.00 per Unit, generating gross proceeds of $402,500,000, which is described in Note 3.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 1,778,750 units (each, a “Private Placement Unit”) at a price of $10.00 per Private Placement Unit in a private placement to FTAC Zeus Sponsor, LLC, a Delaware limited liability company (together with FTAC Zeus Advisors, LLC, the “Sponsor”), generating gross proceeds of $17,787,500, which is described in Note 4.

Transaction costs amounted to $24,712,590, consisting of $7,000,000 of underwriting fees, $17,150,000 of deferred underwriting fees, $6,860,000 of deferred advisory fees, and $3,362,590 of other offering costs, which were offset by a $9,660,000 reimbursement for the financial advisory fee (see Note 6). In addition, cash of $4,775,000 was originally held outside of the Trust Account (as defined below) and is available for the payment of offering costs and for working capital purposes.

Following the closing of the Initial Public Offering on November 23, 2021, an amount of $408,537,500 ($10.15 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”), and was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below.

In accordance with the rules of Nasdaq, the initial Business Combination must occur with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned) at the time the Company signs a definitive agreement for the initial Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

Except for interest income released to the Company for the payment of taxes or dissolution expenses, none of the funds held in the Trust Account will be released, subject to the requirements of law, until the earlier of (i) the consummation of the initial Business Combination; (ii) the redemption of the Public Shares if the Company is unable to consummate a Business Combination within 21 months from the closing of the Initial Public Offering (the “Completion Window”) subject to applicable law; or (iii) the redemption of any Public Shares properly tendered in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete the initial Business Combination within the Completion Window; or (iv) otherwise upon the liquidation or if the board of directors resolves to liquidate the Trust Account and ceases to pursue the consummation of a Business Combination prior to the expiration of the Completion Window (the board of directors may determine to liquidate the Trust Account prior to such expiration if it determines, in its business judgment, that it is improbable within the remaining time to identify an attractive Business Combination or satisfy regulatory and other business and legal requirements to consummate a Business Combination). The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the public stockholders.

FTAC ZEUS ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

The Company will provide the public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial Business Combination either in connection with a stockholder meeting called to approve the Business Combination or by means of a tender offer. The decision as to whether the Company will seek stockholder approval of an Initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek stockholder approval under the law or stock exchange listing requirement. The Company’s public stockholders are entitled to redeem their Public Shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, divided by the number of then outstanding Public Shares. The amount in the Trust Account was initially $10.15 per Public Share.

The shares of common stock subject to redemption are recorded at redemption value and classified as temporary equity in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company’s Class A common stock is not a “penny stock” upon consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

The Company’s amended and restated certificate of incorporation provides that the Company will have until the end of the Completion Window to consummate the initial Business Combination. If the Company has not consummated a Business Combination within the Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem all Public Shares then outstanding at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

The initial stockholders, officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed (1) to waive their redemption rights with respect to any Founder Shares (as described in Note 5), placement shares and Public Shares held by them, as applicable, in connection with the completion of the initial Business Combination; (2) to waive their redemption rights with respect to any Founder Shares, placement shares and Public Shares held by them in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to provide for the redemption of the Public Shares in connection with an initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated the initial Business Combination within the Completion Window or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity; and (3) to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares or placement shares they hold if the Company fails to complete the initial Business Combination within the Completion Window (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Completion Window). If the Company submits the initial Business Combination to the public stockholders for a vote, the initial stockholders, officers and directors have agreed to vote any Founder Shares, any placement shares and any Public Shares held by them in favor of the initial Business Combination.

Liquidity and Capital Resources

As of June 30, 2023, the Company had $213,035 in its operating bank account and a working capital deficit of $785,565, net of franchise tax payable and income tax payable. In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may provide the Company with Working Capital Loans (as defined below) (see Note 5), but are not obligated to do so.

FTAC ZEUS ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

Going Concern

In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until August 23, 2023 to consummate a Business Combination. It is uncertain whether the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and date for mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management intends to consummate a Business Combination by August 23, 2023. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after August 23, 2023.

NOTE 2. SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, 2022, as filed with the SEC on March 17, 2023. The interim results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

FTAC ZEUS ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

Use of Estimates

The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

As of June 30, 2023 and December 31, 2022, the Company had $213,035 and $557,193 in cash, respectively. The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022.

Investments Held in Trust Account

As of June 30, 2023 and December 31, 2022, the Company had $420,376,676 and $413,569,723 in investments held in the Trust Account which were invested in BLF Treasury Trust Fund. Net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units were placed in the Trust Account which is invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income earned on investments held in trust account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

Offering Costs

The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering”. Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering date that are directly related to the Initial Public Offering. Offering costs directly attributable to the issuance of an equity contract to be classified in equity are recorded as a reduction of equity. Offering costs for equity contracts that are classified as assets and liabilities are expensed immediately. As of June 30, 2023 and December 31, 2022, the Company incurred offering costs amounting to $24,712,590, consisting of $7,000,000 of underwriting fees, $17,150,000 of deferred underwriting fees, $6,860,000 of deferred advisory fees, and $3,362,590 of other offering costs offset by a $9,660,000 reimbursement for the financial advisory fee. These offering costs were allocated between components of temporary and permanent equity based on the relative fair value of these components.

FTAC ZEUS ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

Net Income (Loss) Per Common Stock

The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Earnings and losses are shared pro rata between the two classes of shares. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 21,014,375 shares of its Class A common stock in the calculation of diluted net income (loss) per share, since their exercise is contingent upon future events. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:

	Three Months Ended June 30,										Six Months Ended June 30,
	2023				2022						2023				2022
		Class A		Class B		Class A			Class B			Class A		Class B		Class A			Class B
Basic and diluted net income (loss) per share
Numerator:
Allocation of net income (loss)	$	2,512,844	$	837,615	$	(332,960	)	$	(110,986	)	$	4,662,315	$	1,554,105	$	(890,467	)	$	(296,822	)
Denominator:
Basic and diluted weighted average shares outstanding		42,028,750		14,009,583		42,028,750			14,009,583			42,028,750		14,009,583		42,028,750			14,009,583
Basic and diluted net income (loss) per share	$	0.06	$	0.06	$	(0.01	)	$	(0.01	)	$	0.11	$	0.11	$	(0.02	)	$	(0.02	)

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified in temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2023 and December 31, 2022, 40,250,000 shares of Class A common stock are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.

The Company recognizes changes in redemption value immediately as they occur. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable common stock resulted in charges against additional paid-in capital and accumulated deficit.

FTAC ZEUS ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature.

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The Company’s financial instruments are classified as either Level 1, Level 2 or Level 3. These tiers include:

●

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

●

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

●

Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Warrant Classification

The Company accounts for the warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in ASC 815-40 under which the warrants meet the criteria for equity treatment and are recorded as equity.

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740-270-25-2 requires that an annual effective tax rate be determined, and such annual effective rate be applied to year to date income in interim periods under ASC 740-270-30-5. As of June 30, 2023 and December 31, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it. The Company’s effective tax rate was (23.56%) and 29.86% for the three months ended June 30, 2023 and 2022, respectively, and (23.82%) and 9.41% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three months ended June 30, 2023 and 2022, due to the valuation allowance on the deferred tax assets.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

FTAC ZEUS ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023
(Unaudited)

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Deposit Insurance Corporation coverage limits of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition. As of June 30, 2023 and December 31, 2022, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these unaudited condensed financial statements, and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements.

Inflation Reduction Act of 2022

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and inhibit the Company’s ability to complete a Business Combination.

FTAC ZEUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2023
(Unaudited)

NOTE 3. INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 40,250,000 Units, which includes the full exercise by the underwriter of its over-allotment option in the amount of 5,250,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant (“public warrant”). Each whole public warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share, subject to adjustment (see Note 7).

All of the 40,250,000 shares of Class A common stock sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity”, and with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity.

As of June 30, 2023 and December 31, 2022, the common stock subject to possible redemption reflected on the condensed balance sheets is reconciled in the following table:

Class A common stock subject to possible redemption, January 1, 2021		408,537,500
Plus:
Accretion of carrying value to redemption value		4,299,069
Class A common stock subject to possible redemption, December 31, 2022		412,836,569
Plus:
Accretion of carrying value to redemption value		7,489,880
Class A common stock subject to possible redemption, June 30, 2023	$	420,326,449

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased in a private placement 1,778,750 Private Placement Units at a price of $10.00 per unit, for a purchase price of $17,787,500.

The Private Placement Units are identical to the Units sold in the Initial Public Offering except that the Private Placement Units (including the underlying placement warrants, the placement shares and the shares of Class A common stock issuable upon exercise of the placement warrants), so long as they are held by the initial purchasers or their permitted transferees, (i) may not, subject to certain limited exceptions, be transferred, assigned or sold until 30 days after the completion of the initial Business Combination, and (ii) are entitled to registration rights.

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

On February 16, 2021, the Sponsor paid $25,000 in exchange for 17,333,333 Class B shares (the “Founder Shares”). The number of Founder Shares was determined based on the expectation that the Founder Shares would represent 25% of the aggregate of the Founder Shares, the placement shares and the issued and outstanding Public Shares after the Initial Public Offering (assuming the initial stockholders did not purchase any Units in the Initial Public Offering). On October 28, 2021, the Sponsor transferred back to the Company 5,302,500 Founder Shares for no consideration. On November 18, 2021, the Company effected a stock dividend of 0.1644733 shares of Class B common stock for each share of Class B common stock outstanding before the dividend. The transfer and dividend left a remaining Founder Share balance outstanding of 14,009,583, of which 1,776,250 Founder Shares were subject to forfeiture. As a result of the underwriter’s election to fully exercise its over-allotment option at the closing of the Initial Public Offering, no Founder Shares remain subject to forfeiture.

The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares (i) with respect to 25% of such shares, until consummation of the initial Business Combination, (ii) with respect to 25% of such shares, until the closing price of the Class A common stock exceeds $12.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, (iii) with respect to 25% of such shares, until the closing price of the Class A common stock exceeds $13.50 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, and (iv) with respect to 25% of such shares, until the closing price of the Class A common stock exceeds $15.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination or earlier, in any case, if, following a Business Combination, the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property. Any permitted transferees would be subject to the same restrictions and other agreements of the initial stockholders with respect to any Founder Shares.

FTAC ZEUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2023
(Unaudited)

Promissory Note — Related Party

On February 12, 2021, the Sponsor agreed to loan the Company up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note was subsequently amended on June 23, 2021 to extend the maturity date to September 30, 2021, and the Note was further amended on October 28, 2021 to extend the maturity date to March 31, 2022. The Note was non-interest bearing and payable on the earlier of March 31, 2022 or the completion of the Initial Public Offering. The outstanding balance under the Note of $122,926 was paid in full on November 23, 2021 and the Note was terminated.

In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). On February 24, 2023, the Sponsor agreed to loan the Company up to $1,500,000 (the “Promissory Note”). The Promissory Note is non-interest bearing and all outstanding amounts under the Promissory Note will be due on the date on which the Company consummates a business combination. If the Company does not consummate a business combination, the Company may use a portion of any funds held outside the Trust Account to repay the Promissory Note; however, no proceeds from the Trust Account may be used for such repayment. If such funds are insufficient to repay the Promissory Note, the unpaid amounts would be forgiven. No portion of the amounts outstanding under the Promissory Note may be converted into units at a price of $10.00 per unit, which would have been permissible as described in the prospectus filed in connection with the Initial Public Offering. As of June 30, 2023 and December 31, 2022, the Company had $750,000 and $0 of outstanding borrowings under the Promissory Note, respectively.

Administrative Services Agreement

On November 18, 2021, the Company entered into an agreement pursuant to which it pays the Sponsor or an affiliate of the Sponsor $40,000 per month for office space, administrative and shared personnel support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. For the three and six months ended June 30, 2023, the Company incurred $120,000 and 240,000 in fees for these services, respectively, of which $120,000 of such fees are reported in accrued expenses in the accompanying condensed balance sheets. For the three and six months ended June 30, 2022, the Company incurred and paid $120,000 and $240,000 in fees for these services, respectively.

Due to Related Party

As of June 30, 2023 and December 31, 2022, due to related party amounted to $21,935, which consists of accrued administrative services fees.

Consulting Fees

Various related parties provide monthly consulting services to the Company. For the three and six months ended June 30, 2023, the Company incurred approximately $227,000 and $539,000 of consulting fees, respectively, which are classified as formation and operating costs in the Company’s unaudited condensed statements of operations and of which approximately $8,000 of such fees are reported in accrued expenses in the accompanying unaudited condensed balance sheets. For the three and six months ended June 30, 2022, the Company incurred and paid approximately $306,000 and $611,000 of consulting fees, respectively, which are classified as formation and operating costs in the Company’s unaudited condensed statements of operations.

FTAC ZEUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2023
(Unaudited)

NOTE 6. COMMITMENTS AND CONTINGENCIES

Registration Rights

Pursuant to a registration rights agreement entered into on November 18, 2021, the holders of the Founder Shares, Private Placement Units (including securities contained therein) and warrants that may be issued upon conversion of loans made by the Sponsor or one of its affiliates have registration rights to require the Company to register a sale of any of its securities held by them (in the case of the Founder Shares, only after conversion to the Class A common stock). These holders are entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities for sale under the Securities Act. In addition, these holders have “piggy-back” registration rights to include such securities in other registration statements filed by the Company and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act.

Warrant Amendments

The warrant agreement provides that the terms of the warrants may be amended without the consent of any stockholder or warrant holder to cure any ambiguity or correct any defective provision or to make any amendments that are necessary in the good faith determination of the board of directors of the Company (taking into account then existing market precedents) to allow for the warrants to continue to be classified as equity in the Company’s financial statements, but requires the approval by the holders of at least 50% of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders of public warrants. Accordingly, the Company may amend the terms of the public warrants (i) in a manner adverse to a holder of public warrants if holders of at least 50% of the then outstanding public warrants approve of such amendment or (ii) to the extent necessary for the warrants in the good faith determination of the board of directors of the Company (taking into account then existing market precedents) to allow for the warrants to continue to be classified as equity in the Company’s financial statements without the consent of any stockholder or warrant holder. Although the Company’s ability to amend the terms of the public warrants with the consent of holders of at least 50% of the then outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash or shares, shorten the exercise period or decrease the number of shares of Class A common stock purchasable upon exercise of a warrant.

Underwriting Agreement

The underwriter agreed to defer until consummation of the Business Combination $17,150,000 of its underwriting commissions, which equals 4.0% of the gross proceeds from the Units sold to the public, excluding any Units purchased pursuant to the underwriter’s overallotment option, and 6.0% of the gross proceeds from the Units sold to the public pursuant to the underwriter’s overallotment option. This amount was placed in the Trust Account and will be released to the underwriter only on completion of an initial Business Combination.

Financial Advisory Fee

The Company engaged Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (“CCM”), to provide financial advisory services in connection with the Initial Public Offering. The Company paid CCM a fee in an amount equal to 0.8% of the aggregate proceeds of the Initial Public Offering (excluding the proceeds of the exercise of the overallotment option) net of underwriter’s expenses, upon the closing of the Initial Public Offering. The Company also engaged CCM to act as an advisor in connection with the Business Combination for which it will earn an advisory fee of 1.6% of the proceeds of the Initial Public Offering (excluding the proceeds of the exercise of the overallotment option) payable at closing of the Business Combination. CCM is also entitled to an advisory fee equal to 2.4% of the aggregate proceeds of the exercise of the overallotment option, payable at the closing of the Business Combination. The underwriter has agreed to reimburse the Company for the fee to CCM as it becomes payable out of the underwriting commissions, including the deferred underwriting commissions payable at closing of the Business Combination. Accordingly, $2,800,000 was received by the Company upon closing of the Initial Public Offering and a reimbursement receivable and deferred advisory fees of $6,860,000 has been reflected in the accompanying condensed balance sheets as of June 30, 2023 and December 31, 2022.

FTAC ZEUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2023
(Unaudited)

NOTE 7. STOCKHOLDERS’ DEFICIT

Preferred Stock

The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. At June 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.

Class A Common Stock

The Company is authorized to issue 90,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. At June 30, 2023 and December 31, 2022, there were 1,778,750 shares of Class A common stock issued and outstanding, excluding 40,250,000 shares of Class A common stock subject to redemption, which are classified as temporary equity (see Note 3).

Class B Common Stock

The Company is authorized to issue 20,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of the Class B common stock are entitled to one vote for each share. Holders of Class B common stock will vote on the election of directors prior to the consummation of a Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law. At June 30, 2023 and December 31, 2022, there were 14,009,583 shares of Class B common stock issued and outstanding.

The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination on a one-for-one basis, subject to adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to the closing of the initial Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 25% of the sum of the total number of all shares of common stock issued and outstanding upon completion of the Initial Public Offering, including placement shares, plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination, excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company (if applicable).

Warrants

As of June 30, 2023 and December 31, 2022, there were 20,125,000 public warrants and 889,375 placement warrants outstanding. Each whole warrant entitles the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to adjustment, at any time commencing 30 days after the completion of the initial Business Combination. The warrants will expire five years after the completion of the initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

FTAC ZEUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2023
(Unaudited)

Redemption of warrants

Redemption of Warrants. Once the warrants become exercisable, the Company may redeem the outstanding warrants:

●

in whole and not in part;

●

at a price of $0.01 per warrant;

●

upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period; and

●

if, and only if, the last sale price of the Class A common stock (or the closing bid price of the Class A common stock in the event the shares of Class A common stock are not traded on any specific trading day) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and the like) for any 20 trading days within a 30 trading day period ending on the third trading day before the Company sends the notice of redemption to the warrant holders.

NOTE 8. FAIR VALUE MEASUREMENTS

The following tables present information about the Company’s assets that are measured at fair value on June 30, 2023 and December 31, 2022, and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

	June 30, 2023		Quoted Prices In Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets:
Marketable securities held in Trust Account	$	420,376,676	$	420,376,676	$	—	$	—

	December 31, 2022		Quoted Prices In Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets:
Marketable securities held in Trust Account	$	413,569,723	$	413,569,723	$	—	$	—

There were no transfers between Levels 1, 2 and 3 for the three and six months ended June 30, 2023 and 2022.

NOTE 9. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this report (this “Quarterly Report”) to “we,” “us” or the “Company” refer to FTAC Zeus Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer collectively to FTAC Zeus Sponsor, LLC and FTAC Zeus Advisors, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated in Delaware on December 11, 2020 and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more target businesses. We intend to effectuate our business combination using cash from the proceeds of our Initial Public Offering and the sale of the Private Placement Units that occurred simultaneously with the completion of our Initial Public Offering, our capital stock, debt or a combination of cash, stock and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a business combination will be successful.

Results of Operations

All activity for the period from December 11, 2020 (inception) through December 31, 2020 was de minimis and related only to our formation. All activity for the period from January 1, 2021 (commencement of operations) through June 30, 2023 relates to our formation, the Initial Public Offering and, after the Initial Public Offering, identifying a target company for an initial Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination, at the earliest. We expect to generate non-operating income in the form of interest income on marketable securities held after the Initial Public Offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended June 30, 2023, we had net income of $3,350,459, which consisted of interest income earned on investments held in Trust Account of $4,967,960, offset by formation and operating costs of $584,730 and provision for income taxes of $1,032,771.

For the six months ended June 30, 2023, we had net income of $6,216,420, which consisted of interest income earned on investments held in Trust Account of $9,356,120, offset by formation and operating costs of $1,195,915 and provision for income taxes of $1,943,785.

For the three months ended June 30, 2022, we had a net loss of $443,946, which consisted of formation and operating costs of $893,496 and provision for income taxes of $102,084, partially offset by interest income earned on investments held in Trust Account of $551,634.

For the six months ended June 30, 2022, we had a net loss of $1,187,289, which consisted of formation and operating costs of $1,677,979 and provision for income taxes of $102,084, partially offset by interest income earned on investments held in Trust Account of $592,774.

Liquidity and Capital Resources

On November 23, 2021, we consummated the Initial Public Offering of 40,250,000 Units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which included the full exercise by the underwriter of its over-allotment option in the amount of 5,250,000 Units, at a price of $10.00 per Unit, generating gross proceeds of $402,500,000.

Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 1,778,750 units (each, a “Private Placement Unit”) at a price of $10.00 per Private Placement Unit in a private placement to our Sponsor, generating gross proceeds of $17,787,500.

Following the closing of the Initial Public Offering, the full exercise of the over-allotment option, and the sale of the Private Placement Units, a total of $408,537,500 ($10.15 per Unit) was placed in the Trust Account and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 of the Investment Company Act, as determined by us, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below.

As of June 30, 2023, we had $213,035 in cash and a working capital deficit of $785,565, net of franchise tax payable and income tax payable. Prior to the completion of our Initial Public Offering, our liquidity needs had been satisfied through a capital contribution from the Sponsor of $25,000 and a loan to us of up to $300,000 by our Sponsor under an unsecured promissory note, which had no outstanding balance as of June 30, 2023. The outstanding balance under the promissory note of $122,926 was paid in full on November 23, 2021 and the promissory note was terminated. On February 24, 2023, the Sponsor agreed to loan the Company up to $1,500,000 (the “Promissory Note”). As of June 30, 2023 and December 31, 2022, we had $750,000 and $0 outstanding borrowings under the Promissory Note.

As of June 30, 2023, we had cash, investments and marketable securities held in the Trust Account of $420,376,676. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account to complete our Business Combination. We may withdraw interest from the Trust Account to pay our taxes. During the six months ended June 30, 2023, we withdrew $2,549,167 of interest income from the Trust Account for that purpose. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

In order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor, or certain of our directors and officers may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. On February 24, 2023, the Sponsor agreed to loan the Company up to $1,500,000 pursuant to the Promissory Note. No portion of the amounts outstanding under the Promissory Note may be converted into units at a price of $10.00 per unit, which would have been permissible as described in the prospectus filed in connection with the Initial Public Offering. We do not expect to seek loans from parties other than our Sponsor or an affiliate of our Sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our Trust Account. As of June 30, 2023 and December 31, 2022, $750,000 and $0 of such loans were outstanding.

We do not believe we will need to raise additional funds (other than pursuant to the Promissory Note) in order to meet the expenditures required for operating our business through the earlier of the consummation of a Business Combination or one year from the date of the financial statements. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our Business Combination. If we are unable to complete our Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

Going Concern

We have until August 23, 2023 to consummate a Business Combination. It is uncertain whether we will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution. We had a working capital deficit of $785,565, net of income taxes payable and franchise taxes payable, as of June 30, 2023; however, we will incur additional expenses as it relates to the consummation of a business combination. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about our ability to continue as a going concern. We intend to consummate a Business Combination by August 23, 2023. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after August 23, 2023.

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2023. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor or an affiliate of the Sponsor a monthly fee of $40,000 for office space, administrative and shared personnel support services to the Company. We began incurring these fees on November 19, 2021 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and our liquidation. For the three and six months ended June 30, 2023 and 2022, we incurred and paid $120,000 and 240,000 in fees for these services, respectively.

Pursuant to a registration rights agreement entered into on November 18, 2021, the holders of the Founder Shares, Private Placement Units (including securities contained therein) and warrants that may be issued upon conversion of loans made by the Sponsor or one of its affiliates have registration rights to require us to register a sale of any of our securities held by them (in the case of the Founder Shares, only after conversion to the Class A common stock). These holders are entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities for sale under the Securities Act. In addition, these holders have “piggy-back” registration rights to include such securities in other registration statements we file and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act.

We engaged Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (“CCM”), to provide financial advisory services in connection with the Initial Public Offering. We paid CCM a fee in an amount equal to 0.8% of the aggregate proceeds of the Initial Public Offering (excluding the proceeds of the exercise of the overallotment option) net of underwriter’s expenses, upon the closing of the Initial Public Offering. We also engaged CCM to act as an advisor in connection with the Business Combination for which it will earn an advisory fee of 1.6% of the proceeds of the Initial Public Offering (excluding the proceeds of the exercise of the overallotment option) payable at closing of the Business Combination. CCM is also entitled to an advisory fee equal to 2.4% of the aggregate proceeds of the exercise of the overallotment option, payable at the closing of the Business Combination. The underwriter has agreed to reimburse us for the fee to CCM as it becomes payable out of the underwriting commissions, including the deferred underwriting commissions payable at closing of the Business Combination. Accordingly, a reimbursement receivable and deferred advisory fee of $6,860,000 has been reflected in the accompanying balance sheets.

Critical Accounting Policies

The preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited financial statements and the reported amounts of expenses during the reporting periods.

Class A Common Stock Subject to Possible Redemption

We account for our Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified in temporary equity. At all other times, common stock is classified as stockholders’ equity. Our Class A common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2023 and December 31, 2022, 40,250,000 shares of Class A common stock are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of our balance sheets.

We recognize changes in redemption value immediately as they occur and adjust the carrying value of redeemable Class A common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A common stock are affected by charges against additional paid in capital and accumulated deficit. This method would view the end of the reporting period as if it were also the redemption date for the security.

Net Income (Loss) Per Common Stock

We have two classes of shares, which are referred to as Class A common stock and Class B common stock. Earnings and losses are shared pro rata between the two classes of shares. We have not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 21,014,375 shares of our Class A common stock in the calculation of diluted net income (loss) per share, since their exercise is contingent upon future events. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share.

Recent Accounting Standards

We do not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our chief executive officer and chief financial officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of June 30, 2023, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that as of June 30, 2023, our disclosure controls and procedures were effective.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

Factors that could cause our actual results to differ materially from those in this Quarterly Report include the risk factors described in our Annual Report on Form 10-K filed with the SEC. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On November 23, 2021, we consummated the Initial Public Offering of 40,250,000 Units. The Units were sold at an offering price of $10.00 per unit, generating total gross proceeds of $402,500,000. Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant (“public warrant”). Each whole public warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share, subject to adjustment. Citigroup Global Markets Inc. served as the sole book-running manager for the initial public offering. The securities in the offering were registered under the Securities Act on registration statements on Form S-1 (Nos. 333-253995 and 333-261195). The SEC declared the registration statements effective on November 18, 2021.

Simultaneously with the consummation of the Initial Public Offering, the Company consummated the private placement of an aggregate of 1,778,750 Private Placement Units to the Sponsor at a price of $10.00 per Private Placement Unit, generating total proceeds of $17,787,500. Each Private Placement Unit consists of one share of Class A common stock and one half of a placement warrant. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

The placement warrants are identical to the public warrants underlying the Units sold in the Initial Public Offering, except that the placement warrants are not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions.

Of the gross proceeds received from the Initial Public Offering, the exercise of the over-allotment option and the sale of the Private Placement Units, an aggregate of $408,537,500 ($10.15 per Unit) was placed in the Trust Account.

We paid a total of $7,000,000 in underwriting discounts and commissions ($2.8 million of which was reimbursed to us to pay the advisory fee due to CCM) and $562,590 for other costs and expenses related to the Initial Public Offering. In addition, the underwriter agreed to defer $17,150,000 in underwriting discounts and commissions (which is currently held in the Trust Account), which will be payable only upon consummation of an initial business combination.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.		Description of Exhibit
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Filed herewith.

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	FTAC ZEUS ACQUISITION CORP.

Date: August 10, 2023	By:	/s/ Ryan M. Gilbert
	Name:	Ryan M. Gilbert
	Title:	President and Chief Executive Officer
		(Principal Executive Officer)

Date: August 10, 2023	By:	/s/ Joseph W. Pooler, Jr.
	Name:	Joseph W. Pooler, Jr.
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

42028750 42028750 42028750 42028750 0.01 0.02 0.06 0.11 14009583 14009583 14009583 14009583 0.01 0.02 0.06 0.11 14009583 14009583 14009583 14009583 42028750 42028750 42028750 42028750 0.01 0.01 0.02 0.02 0.06 0.06 0.11 0.11 false --12-31 Q2 0001844270 0001844270 2023-01-01 2023-06-30 0001844270 zing:ClassACommonStockParValue00001PerShareMember 2023-01-01 2023-06-30 0001844270 zing:WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockMember 2023-01-01 2023-06-30 0001844270 zing:UnitsEachConsistingOfOneShareOfClassACommonStockAndOneHalfOfOneRedeemableWarrantMember 2023-01-01 2023-06-30 0001844270 us-gaap:CommonClassAMember 2023-08-10 0001844270 us-gaap:CommonClassBMember 2023-08-10 0001844270 2023-06-30 0001844270 2022-12-31 0001844270 us-gaap:CommonClassAMember 2023-06-30 0001844270 us-gaap:CommonClassAMember 2022-12-31 0001844270 us-gaap:CommonClassBMember 2023-06-30 0001844270 us-gaap:CommonClassBMember 2022-12-31 0001844270 2023-04-01 2023-06-30 0001844270 2022-04-01 2022-06-30 0001844270 2022-01-01 2022-06-30 0001844270 us-gaap:CommonClassAMember 2023-04-01 2023-06-30 0001844270 us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0001844270 us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0001844270 us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001844270 us-gaap:CommonClassBMember 2023-04-01 2023-06-30 0001844270 us-gaap:CommonClassBMember 2022-04-01 2022-06-30 0001844270 us-gaap:CommonClassBMember 2023-01-01 2023-06-30 0001844270 us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001844270 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001844270 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001844270 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001844270 us-gaap:RetainedEarningsMember 2022-12-31 0001844270 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001844270 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001844270 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001844270 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001844270 2023-01-01 2023-03-31 0001844270 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001844270 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001844270 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001844270 us-gaap:RetainedEarningsMember 2023-03-31 0001844270 2023-03-31 0001844270 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001844270 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001844270 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001844270 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001844270 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-06-30 0001844270 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-06-30 0001844270 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001844270 us-gaap:RetainedEarningsMember 2023-06-30 0001844270 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001844270 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001844270 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001844270 us-gaap:RetainedEarningsMember 2021-12-31 0001844270 2021-12-31 0001844270 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001844270 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001844270 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001844270 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001844270 2022-01-01 2022-03-31 0001844270 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001844270 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001844270 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001844270 us-gaap:RetainedEarningsMember 2022-03-31 0001844270 2022-03-31 0001844270 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001844270 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001844270 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001844270 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001844270 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-06-30 0001844270 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001844270 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001844270 us-gaap:RetainedEarningsMember 2022-06-30 0001844270 2022-06-30 0001844270 us-gaap:IPOMember 2021-11-23 0001844270 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2021-11-23 0001844270 us-gaap:OverAllotmentOptionMember 2021-11-23 0001844270 2021-11-01 2021-11-23 0001844270 us-gaap:PrivatePlacementMember 2023-01-01 2023-06-30 0001844270 us-gaap:PrivatePlacementMember 2023-06-30 0001844270 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-06-30 0001844270 us-gaap:IPOMember 2023-01-01 2023-06-30 0001844270 us-gaap:IPOMember 2023-06-30 0001844270 us-gaap:IPOMember 2021-11-01 2021-11-23 0001844270 2022-01-01 2022-12-31 0001844270 2022-08-01 2022-08-16 0001844270 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-01-01 2023-06-30 0001844270 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2023-01-01 2023-06-30 0001844270 us-gaap:OverAllotmentOptionMember 2023-06-30 0001844270 zing:BusinessCombinationsMember us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0001844270 us-gaap:CommonClassBMember 2021-02-16 2021-02-16 0001844270 2021-02-16 2021-02-16 0001844270 2021-10-28 2021-10-28 0001844270 us-gaap:CommonClassBMember 2021-11-01 2021-11-18 0001844270 us-gaap:CommonClassBMember 2021-11-18 0001844270 2021-02-12 0001844270 2021-02-01 2021-02-12 0001844270 2021-11-23 0001844270 2023-02-24 0001844270 2023-02-24 2023-02-24 0001844270 2021-11-01 2021-11-18 0001844270 zing:ConsultingFeesMember 2023-04-01 2023-06-30 0001844270 zing:ConsultingFeesMember 2023-01-01 2023-06-30 0001844270 zing:ConsultingFeesMember 2022-04-01 2022-06-30 0001844270 zing:ConsultingFeesMember 2022-01-01 2022-06-30 0001844270 zing:PublicWarrantsMember 2023-01-01 2023-06-30 0001844270 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:OverAllotmentOptionMember 2023-01-01 2023-06-30 0001844270 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-06-30 0001844270 us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001844270 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-01-01 2023-06-30 0001844270 zing:PublicWarrantsMember 2023-06-30 0001844270 zing:PublicWarrantsMember 2022-12-31 0001844270 us-gaap:PrivatePlacementMember 2022-12-31 0001844270 zing:BusinessCombinationMember us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0001844270 us-gaap:FairValueInputsLevel1Member 2023-06-30 0001844270 us-gaap:FairValueInputsLevel2Member 2023-06-30 0001844270 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001844270 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001844270 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001844270 us-gaap:FairValueInputsLevel3Member 2022-12-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Ryan M. Gilbert, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of FTAC Zeus Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 10, 2023

	/s/ Ryan M. Gilbert
	Ryan M. Gilbert
	President and Chief Executive Officer
	(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Joseph W. Pooler, Jr., certify that:

1.	I have reviewed this quarterly report on Form 10-Q of FTAC Zeus Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 10, 2023

	/s/ Joseph W. Pooler, Jr.
	Joseph W. Pooler, Jr.
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of FTAC Zeus Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Ryan M. Gilbert, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 10, 2023

	/s/ Ryan M. Gilbert
	Ryan M. Gilbert
	President and Chief Executive Officer
	(Principal Executive Officer)

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of FTAC Zeus Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Joseph W. Pooler, Jr., Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 10, 2023

	/s/ Joseph W. Pooler, Jr.
	Joseph W. Pooler, Jr.
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2023	Aug. 10, 2023
Document Information Line Items
Entity Registrant Name	FTAC ZEUS ACQUISITION CORP.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001844270
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Jun. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-41082
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-4260524
Entity Address, Address Line One	2929 Arch Street
Entity Address, Address Line Two	Suite 1703
Entity Address, City or Town	Philadelphia
Entity Address, Country	PA
Entity Address, Postal Zip Code	19104
City Area Code	(215)
Local Phone Number	701-9555
Entity Interactive Data Current	Yes
Class A common stock, par value $0.0001 per share
Document Information Line Items
Trading Symbol	ZING
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Security Exchange Name	NASDAQ
Warrants, each whole warrant exercisable for one share of Class A common stock
Document Information Line Items
Trading Symbol	ZINGW
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Class A common stock
Security Exchange Name	NASDAQ
Units, each consisting of one share of Class A common stock and one- half of one redeemable warrant
Document Information Line Items
Trading Symbol	ZINGU
Title of 12(b) Security	Units, each consisting of one share of Class A common stock and one- half of one redeemable warrant
Security Exchange Name	NASDAQ
Class A Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		42,028,750
Class B Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		14,009,583

Condensed Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 213,035	$ 557,193
Prepaid expenses	52,376	9,499
Total Current Assets	265,411	566,692
Reimbursement receivable	6,860,000	6,860,000
Investments held in Trust Account	420,376,676	413,569,723
Total Assets	427,502,087	420,996,415
Current liabilities
Accounts payable and accrued expenses	299,041	236,574
Income taxes payable	30,229	553,444
Due to related party	21,935	21,935
Promissory note – related party	750,000
Total current liabilities	1,101,205	811,953
Deferred underwriting fee payable	17,150,000	17,150,000
Deferred advisory fees	6,860,000	6,860,000
Total liabilities	25,111,205	24,821,953
Commitments and Contingencies
Class A common stock subject to possible redemption, $0.0001 par value; 40,250,000 issued and outstanding shares at a redemption value of $10.44 and $10.26 per share as of June 30, 2023 and December 31, 2022, respectively	420,326,449	412,836,569
Stockholders’ Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of June 30, 2023 and December 31, 2022
Class A common stock, $0.0001 par value; 90,000,000 shares authorized; 1,778,750 shares issued and outstanding (excluding 40,250,000 shares subject to possible redemption) as of June 30, 2023 and December 31, 2022	178	178
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 14,009,583 shares issued and outstanding as of June 30, 2023 and December 31, 2022	1,401	1,401
Accumulated deficit	(17,937,146)	(16,663,686)
Total Stockholders’ Deficit	(17,935,567)	(16,662,107)
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit	$ 427,502,087	$ 420,996,415

Condensed Balance Sheets (Parentheticals) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Preferred stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Class A Common Stock
Common stock subject to possible redemption, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock subject to possible redemption, shares issued	40,250,000	40,250,000
Common stock subject to possible redemption, shares outstanding	40,250,000	40,250,000
Common stock subject to possible redemption value of per share (in Dollars per share)	$ 10.44	$ 10.26
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	90,000,000	90,000,000
Common stock, shares issued	1,778,750	1,778,750
Common stock, shares outstanding	1,778,750	1,778,750
Class B Common Stock
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	14,009,583	14,009,583
Common stock, shares outstanding	14,009,583	14,009,583

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Formation and operating costs	$ 584,730	$ 893,496	$ 1,195,915	$ 1,677,979
Loss from operations	(584,730)	(893,496)	(1,195,915)	(1,677,979)
Other income:
Interest income earned on investments held in trust account	4,967,960	551,634	9,356,120	592,774
Total other income, net	4,967,960	551,634	9,356,120	592,774
Income (Loss) before provision for income taxes	4,383,230	(341,862)	8,160,205	(1,085,205)
Provision for income taxes	(1,032,771)	(102,084)	(1,943,785)	(102,084)
Net income (loss)	$ 3,350,459	$ (443,946)	$ 6,216,420	$ (1,187,289)
Class A Common Stock
Other income:
Basic weighted average shares outstanding, common stock (in Shares)	42,028,750	42,028,750	42,028,750	42,028,750
Basic net income (loss) per common stock, common stock (in Dollars per share)	$ 0.06	$ (0.01)	$ 0.11	$ (0.02)
Class B Common Stock
Other income:
Basic weighted average shares outstanding, common stock (in Shares)	14,009,583	14,009,583	14,009,583	14,009,583
Basic net income (loss) per common stock, common stock (in Dollars per share)	$ 0.06	$ (0.01)	$ 0.11	$ (0.02)

Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Class A Common Stock
Diluted weighted average shares outstanding, common stock	42,028,750	42,028,750	42,028,750	42,028,750
Diluted net loss per common stock, common stock	$ 0.06	$ (0.01)	$ 0.11	$ (0.02)
Class B Common Stock
Diluted weighted average shares outstanding, common stock	14,009,583	14,009,583	14,009,583	14,009,583
Diluted net loss per common stock, common stock	$ 0.06	$ (0.01)	$ 0.11	$ (0.02)

Condensed Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Class A Common Stock	Class B Common Stock	Accumulated Deficit	Total
Balance at Dec. 31, 2021	$ 178	$ 1,401	$ (13,743,025)	$ (13,741,446)
Balance (in Shares) at Dec. 31, 2021	1,778,750	14,009,583
Net income (loss)			(743,343)	(743,343)
Balance at Mar. 31, 2022	$ 178	$ 1,401	(14,486,368)	(14,484,789)
Balance (in Shares) at Mar. 31, 2022	1,778,750	14,009,583
Balance at Dec. 31, 2021	$ 178	$ 1,401	(13,743,025)	(13,741,446)
Balance (in Shares) at Dec. 31, 2021	1,778,750	14,009,583
Net income (loss)				(1,187,289)
Balance at Jun. 30, 2022	$ 178	$ 1,401	(15,277,983)	(15,276,404)
Balance (in Shares) at Jun. 30, 2022	1,778,750	14,009,583
Balance at Mar. 31, 2022	$ 178	$ 1,401	(14,486,368)	(14,484,789)
Balance (in Shares) at Mar. 31, 2022	1,778,750	14,009,583
Accretion of Class A common stock subject to possible redemption			(347,669)	(347,669)
Net income (loss)			(443,946)	(443,946)
Balance at Jun. 30, 2022	$ 178	$ 1,401	(15,277,983)	(15,276,404)
Balance (in Shares) at Jun. 30, 2022	1,778,750	14,009,583
Balance at Dec. 31, 2022	$ 178	$ 1,401	(16,663,686)	(16,662,107)
Balance (in Shares) at Dec. 31, 2022	1,778,750	14,009,583
Accretion of Class A common stock subject to possible redemption			(3,654,690)	(3,654,690)
Net income (loss)			2,865,961	2,865,961
Balance at Mar. 31, 2023	$ 178	$ 1,401	(17,452,415)	(17,450,836)
Balance (in Shares) at Mar. 31, 2023	1,778,750	14,009,583
Balance at Dec. 31, 2022	$ 178	$ 1,401	(16,663,686)	(16,662,107)
Balance (in Shares) at Dec. 31, 2022	1,778,750	14,009,583
Net income (loss)				6,216,420
Balance at Jun. 30, 2023	$ 178	$ 1,401	(17,937,146)	(17,935,567)
Balance (in Shares) at Jun. 30, 2023	1,778,750	14,009,583
Balance at Mar. 31, 2023	$ 178	$ 1,401	(17,452,415)	(17,450,836)
Balance (in Shares) at Mar. 31, 2023	1,778,750	14,009,583
Accretion of Class A common stock subject to possible redemption			(3,835,190)	(3,835,190)
Net income (loss)			3,350,459	3,350,459
Balance at Jun. 30, 2023	$ 178	$ 1,401	$ (17,937,146)	$ (17,935,567)
Balance (in Shares) at Jun. 30, 2023	1,778,750	14,009,583

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ 6,216,420	$ (1,187,289)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest income earned on investments held in trust account	(9,356,120)	(592,774)
Changes in operating assets and liabilities:
Prepaid expenses	(42,877)	(82,821)
Income taxes payable	(523,215)	102,084
Accounts payable and accrued expenses	62,467	84,678
Net cash used in operating activities	(3,643,325)	(1,676,122)
Cash Flows from Investing Activities:
Cash withdrawn from Trust Account for tax purposes	2,549,167	35,733
Net cash provided by investing activities	2,549,167	35,733
Cash Flows from Financing Activities:
Proceeds from promissory note – related party	750,000
Repayment of advances from related party		(445)
Net cash provided by (used in) financing activities	750,000	(445)
Net Change in Cash	(344,158)	(1,640,834)
Cash – Beginning of period	557,193	3,474,184
Cash – End of period	213,035	1,833,350
Supplementary cash flow information:
Cash paid for income taxes	$ 2,467,000

Organization and Business Operations

6 Months Ended

Jun. 30, 2023

Organization and Business Operations [Abstract]

ORGANIZATION AND BUSINESS OPERATIONS

NOTE 1. ORGANIZATION AND BUSINESS OPERATIONS

Liquidity and Capital Resources

Going Concern

Significant Accounting Policies

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Emerging Growth Company Status

Use of Estimates

Cash and Cash Equivalents

Investments Held in Trust Account

Offering Costs

Net Income (Loss) Per Common Stock

	Three Months Ended June 30,										Six Months Ended June 30,
	2023				2022						2023				2022
		Class A		Class B		Class A			Class B			Class A		Class B		Class A			Class B
Basic and diluted net income (loss) per share
Numerator:
Allocation of net income (loss)	$	2,512,844	$	837,615	$	(332,960	)	$	(110,986	)	$	4,662,315	$	1,554,105	$	(890,467	)	$	(296,822	)
Denominator:
Basic and diluted weighted average shares outstanding		42,028,750		14,009,583		42,028,750			14,009,583			42,028,750		14,009,583		42,028,750			14,009,583
Basic and diluted net income (loss) per share	$	0.06	$	0.06	$	(0.01	)	$	(0.01	)	$	0.11	$	0.11	$	(0.02	)	$	(0.02	)

Class A Common Stock Subject to Possible Redemption

Fair Value of Financial Instruments

●

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

●

Warrant Classification

Income Taxes

Concentration of Credit Risk

Recent Accounting Pronouncements

Risks and Uncertainties

Inflation Reduction Act of 2022

Initial Public Offering

6 Months Ended

Jun. 30, 2023

Initial Public Offering [Abstract]

INITIAL PUBLIC OFFERING

NOTE 3. INITIAL PUBLIC OFFERING

As of June 30, 2023 and December 31, 2022, the common stock subject to possible redemption reflected on the condensed balance sheets is reconciled in the following table:

Class A common stock subject to possible redemption, January 1, 2021		408,537,500
Plus:
Accretion of carrying value to redemption value		4,299,069
Class A common stock subject to possible redemption, December 31, 2022		412,836,569
Plus:
Accretion of carrying value to redemption value		7,489,880
Class A common stock subject to possible redemption, June 30, 2023	$	420,326,449

Private Placement

6 Months Ended

Jun. 30, 2023

Private Placement [Abstract]

PRIVATE PLACEMENT

NOTE 4. PRIVATE PLACEMENT

Related Party Transactions

6 Months Ended

Jun. 30, 2023

RELATED PARTY TRANSACTIONS

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

Promissory Note — Related Party

Administrative Services Agreement

Due to Related Party

As of June 30, 2023 and December 31, 2022, due to related party amounted to $21,935, which consists of accrued administrative services fees.

Consulting Fees

Commitments and Contingencies

6 Months Ended

Jun. 30, 2023

Commitments and Contingencies [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 6. COMMITMENTS AND CONTINGENCIES

Registration Rights

Warrant Amendments

Underwriting Agreement

Financial Advisory Fee

FTAC ZEUS ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2023
(Unaudited)

Stockholders’ Deficit

6 Months Ended

Jun. 30, 2023

Stockholders’ Deficit [Abstract]

STOCKHOLDERS’ DEFICIT

NOTE 7. STOCKHOLDERS’ DEFICIT

Preferred Stock

Class A Common Stock

Class B Common Stock

Warrants

Redemption of warrants

Redemption of Warrants. Once the warrants become exercisable, the Company may redeem the outstanding warrants:

●

in whole and not in part;

●

at a price of $0.01 per warrant;

●

upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period; and

●

Fair Value Measurements

6 Months Ended

Jun. 30, 2023

Fair Value Measurements [Abstract]

FAIR VALUE MEASUREMENTS

NOTE 8. FAIR VALUE MEASUREMENTS

	June 30, 2023		Quoted Prices In Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets:
Marketable securities held in Trust Account	$	420,376,676	$	420,376,676	$	—	$	—

	December 31, 2022		Quoted Prices In Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets:
Marketable securities held in Trust Account	$	413,569,723	$	413,569,723	$	—	$	—

There were no transfers between Levels 1, 2 and 3 for the three and six months ended June 30, 2023 and 2022.

Subsequent Events

6 Months Ended

Jun. 30, 2023

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 9. SUBSEQUENT EVENTS

Accounting Policies, by Policy (Policies)

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Emerging Growth Company Status

Emerging Growth Company Status

Use of Estimates

Use of Estimates

Cash and Cash Equivalents

Cash and Cash Equivalents

Investments Held in Trust Account

Investments Held in Trust Account

Offering Costs

Offering Costs

Net Income (Loss) per Common Stock

Net Income (Loss) Per Common Stock

	Three Months Ended June 30,										Six Months Ended June 30,
	2023				2022						2023				2022
		Class A		Class B		Class A			Class B			Class A		Class B		Class A			Class B
Basic and diluted net income (loss) per share
Numerator:
Allocation of net income (loss)	$	2,512,844	$	837,615	$	(332,960	)	$	(110,986	)	$	4,662,315	$	1,554,105	$	(890,467	)	$	(296,822	)
Denominator:
Basic and diluted weighted average shares outstanding		42,028,750		14,009,583		42,028,750			14,009,583			42,028,750		14,009,583		42,028,750			14,009,583
Basic and diluted net income (loss) per share	$	0.06	$	0.06	$	(0.01	)	$	(0.01	)	$	0.11	$	0.11	$	(0.02	)	$	(0.02	)

Class A Common Stock Subject to Possible Redemption

Class A Common Stock Subject to Possible Redemption

Fair Value of Financial Instruments

Fair Value of Financial Instruments

●

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

●

Warrant Classification

Warrant Classification

Income Taxes

Income Taxes

Concentration of Credit Risk

Concentration of Credit Risk

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Risks and Uncertainties

Risks and Uncertainties

Inflation Reduction Act of 2022

Inflation Reduction Act of 2022

Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Schedule of Basic and Diluted Net Income (Loss) Per Share for Each Class of Common Stock

The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:

	Three Months Ended June 30,										Six Months Ended June 30,
	2023				2022						2023				2022
		Class A		Class B		Class A			Class B			Class A		Class B		Class A			Class B
Basic and diluted net income (loss) per share
Numerator:
Allocation of net income (loss)	$	2,512,844	$	837,615	$	(332,960	)	$	(110,986	)	$	4,662,315	$	1,554,105	$	(890,467	)	$	(296,822	)
Denominator:
Basic and diluted weighted average shares outstanding		42,028,750		14,009,583		42,028,750			14,009,583			42,028,750		14,009,583		42,028,750			14,009,583
Basic and diluted net income (loss) per share	$	0.06	$	0.06	$	(0.01	)	$	(0.01	)	$	0.11	$	0.11	$	(0.02	)	$	(0.02	)

Initial Public Offering (Tables)

6 Months Ended

Jun. 30, 2023

Initial Public Offering [Abstract]

Schedule of Common Stock Subject to Possible Redemption Reflected on Condensed Balance Sheets

As of June 30, 2023 and December 31, 2022, the common stock subject to possible redemption reflected on the condensed balance sheets is reconciled in the following table:

Class A common stock subject to possible redemption, January 1, 2021		408,537,500
Plus:
Accretion of carrying value to redemption value		4,299,069
Class A common stock subject to possible redemption, December 31, 2022		412,836,569
Plus:
Accretion of carrying value to redemption value		7,489,880
Class A common stock subject to possible redemption, June 30, 2023	$	420,326,449

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2023

Fair Value Measurements [Abstract]

Schedule of Fair Value Hierarchy of the Valuation Inputs

	June 30, 2023		Quoted Prices In Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets:
Marketable securities held in Trust Account	$	420,376,676	$	420,376,676	$	—	$	—

	December 31, 2022		Quoted Prices In Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets:
Marketable securities held in Trust Account	$	413,569,723	$	413,569,723	$	—	$	—

Organization and Business Operations (Details) - USD ($)	1 Months Ended	6 Months Ended
	Nov. 23, 2021	Jun. 30, 2023
Organization and Business Operations (Details) [Line Items]
Gross proceeds	$ 402,500,000
Underwriting fees		$ 7,000,000
Other offering cost		3,362,590
Financial advisory fee		9,660,000
Cash available for distribution		$ 4,775,000
Fair market value, percentage		80.00%
Ownership percentage		50.00%
Redeem public shares, percentage		100.00%
Share price (in Dollars per share)		$ 10.15
Dissolution expenses		$ 100,000
Operating bank account amount		213,035
Working capital amount		785,565
IPO [Member]
Organization and Business Operations (Details) [Line Items]
Share issued (in Shares)	40,250,000
Share price (in Dollars per share)	$ 10.15
Deferred underwriting fees		17,150,000
Deferred advisory fees		$ 6,860,000
Net proceeds	$ 408,537,500
Over-Allotment Option [Member]
Organization and Business Operations (Details) [Line Items]
Share price (in Dollars per share)	$ 10
Private Placement [Member]
Organization and Business Operations (Details) [Line Items]
Share price (in Dollars per share)		$ 10
Sale of stock units (in Shares)		1,778,750
Gross proceeds		$ 17,787,500
Class A Common Stock [Member] \| Over-Allotment Option [Member]
Organization and Business Operations (Details) [Line Items]
Share issued (in Shares)	5,250,000
Business Combination [Member]
Organization and Business Operations (Details) [Line Items]
Transaction costs		$ 24,712,590
Percentage of public shares		100.00%

Significant Accounting Policies (Details) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
Significant Accounting Policies (Details) - USD ($)	Aug. 16, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Significant Accounting Policies (Details) [Line Items]
Cash		$ 213,035		$ 213,035		$ 557,193
Investments held in trust account		420,376,676		420,376,676		413,569,723
Incurred offering costs		24,712,590		24,712,590		24,712,590
Underwriting fees				7,000,000		7,000,000
Deferred underwriting fees				17,150,000		17,150,000
Deferred advisory fees				6,860,000		6,860,000
Other offering costs		3,362,590		3,362,590		3,362,590
Reimbursement financial advisory fee		$ 9,660,000		$ 9,660,000		$ 9,660,000
Effective tax rate		(23.56%)	29.86%	23.82%	9.41%
Statutory tax rate		21.00%	21.00%
Federal deposit insurance corporation coverage				$ 250,000
U.S. federal tax percentage	1.00%
Fair market value percentage	1.00%
Class A Common Stock [Member]
Significant Accounting Policies (Details) [Line Items]
Aggregate purchase shares (in Shares)				21,014,375
Temporary equity redemption value (in Shares)		40,250,000		40,250,000		40,250,000

Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share for Each Class of Common Stock - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Class A [Member]
Numerator:
Allocation of net income (loss)	$ 2,512,844	$ (332,960)	$ 4,662,315	$ (890,467)
Denominator:
Basic and diluted weighted average shares outstanding	42,028,750	42,028,750	42,028,750	42,028,750
Basic and diluted net income (loss) per share	$ 0.06	$ (0.01)	$ 0.11	$ (0.02)
Class B [Member]
Numerator:
Allocation of net income (loss)	$ 837,615	$ (110,986)	$ 1,554,105	$ (296,822)
Denominator:
Basic and diluted weighted average shares outstanding	14,009,583	14,009,583	14,009,583	14,009,583
Basic and diluted net income (loss) per share	$ 0.06	$ (0.01)	$ 0.11	$ (0.02)

Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share for Each Class of Common Stock (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Class A [Member]
Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share for Each Class of Common Stock (Parentheticals) [Line Items]
Diluted weighted average shares outstanding	42,028,750	42,028,750	42,028,750	42,028,750
Diluted net income (loss) per share	$ 0.06	$ (0.01)	$ 0.11	$ (0.02)
Class B [Member]
Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share for Each Class of Common Stock (Parentheticals) [Line Items]
Diluted weighted average shares outstanding	14,009,583	14,009,583	14,009,583	14,009,583
Diluted net income (loss) per share	$ 0.06	$ (0.01)	$ 0.11	$ (0.02)

Initial Public Offering (Details)	6 Months Ended
Initial Public Offering (Details)	Jun. 30, 2023 $ / shares shares
Initial Public Offering Details [Abstract]
Exercise price per share (in Dollars per share) \| $ / shares	$ 11.5
Over-Allotment Option [Member]
Initial Public Offering Details [Abstract]
Purchase price per share (in Dollars per share) \| $ / shares	$ 10
Class A Common Stock [Member] \| Initial Public Offering [Member]
Initial Public Offering Details [Abstract]
Sold units	40,250,000
Class A Common Stock [Member] \| Over-Allotment Option [Member]
Initial Public Offering Details [Abstract]
Sold units	5,250,000
Business Combination [Member] \| Class A Common Stock [Member]
Initial Public Offering Details [Abstract]
Sold units	40,250,000

Initial Public Offering (Details) - Schedule of Common Stock Subject to Possible Redemption Reflected on Condensed Balance Sheets - USD ($)	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Schedule of common stock subject to possible redemption reflected on condensed balance sheets [Abstract]
Class A common stock subject to possible redemption, beginning		$ 408,537,500
Class A common stock subject to possible redemption, ending	$ 420,326,449	412,836,569
Plus:
Accretion of carrying value to redemption value	$ 7,489,880	$ 4,299,069

Private Placement (Details) - Private Placement [Member]	6 Months Ended
	Jun. 30, 2023 USD ($) $ / shares shares
Private Placement (Details) [Line Items]
Purchase of private placement \| shares	1,778,750
Price per share \| $ / shares	$ 10
Purchase price \| $	$ 17,787,500

Related Party Transactions (Details) - USD ($)					1 Months Ended	3 Months Ended		6 Months Ended
Related Party Transactions (Details) - USD ($)	Feb. 24, 2023	Oct. 28, 2021	Feb. 16, 2021	Feb. 12, 2021	Nov. 18, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Nov. 23, 2021
Related Party Transactions (Details) [Line Items]
Sponsor shares (in Shares)		5,302,500
Aggregate founder shares percentage			25.00%
Business combination, description								The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares (i) with respect to 25% of such shares, until consummation of the initial Business Combination, (ii) with respect to 25% of such shares, until the closing price of the Class A common stock exceeds $12.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, (iii) with respect to 25% of such shares, until the closing price of the Class A common stock exceeds $13.50 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, and (iv) with respect to 25% of such shares, until the closing price of the Class A common stock exceeds $15.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination or earlier, in any case, if, following a Business Combination, the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property.
Cover expenses	$ 1,500,000			$ 300,000
Maturity date, description				The Note was subsequently amended on June 23, 2021 to extend the maturity date to September 30, 2021, and the Note was further amended on October 28, 2021 to extend the maturity date to March 31, 2022.
Outstanding balance						$ 750,000		$ 750,000		$ 0	$ 122,926
Convertible unit price (in Dollars per share)	$ 10
Office space, price					$ 40,000
Incurred and fees paid for services						120,000	$ 120,000	240,000	$ 240,000
Accrued expenses								120,000
Due to related party amount						21,935		21,935		$ 21,935
Class B Common Stock [Member]
Related Party Transactions (Details) [Line Items]
Amount of sponsor paid			$ 25,000
Sponsor shares (in Shares)			17,333,333
Common stock dividend (in Shares)					0.1644733
Founder shares (in Shares)					14,009,583
Founder shares forfeited (in Shares)					1,776,250
Consulting Fees [Member]
Related Party Transactions (Details) [Line Items]
Incurred and fees paid for services						$ 227,000	$ 306,000	539,000	$ 611,000
Accrued expenses								$ 8,000

Commitments and Contingencies (Details) - USD ($)	6 Months Ended
Commitments and Contingencies (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Commitments and Contingencies (Details) [Line Items]
Percentage of public warrant	50.00%
Warrant amendments, description	(i) in a manner adverse to a holder of public warrants if holders of at least 50% of the then outstanding public warrants approve of such amendment or (ii) to the extent necessary for the warrants in the good faith determination of the board of directors of the Company (taking into account then existing market precedents) to allow for the warrants to continue to be classified as equity in the Company’s financial statements without the consent of any stockholder or warrant holder.
Initial public offering closing (in Dollars)	$ 2,800,000
Deferred advisory fees (in Dollars)	$ 6,860,000	$ 6,860,000
Over-Allotment Option [Member]
Commitments and Contingencies (Details) [Line Items]
Percentage of gross proceeds	6.00%
Advisory fee percentage	2.40%
Initial Public Offering [Member]
Commitments and Contingencies (Details) [Line Items]
Aggregate proceeds percentage	0.80%
Advisory fee percentage	1.60%
Public Warrants [Member]
Commitments and Contingencies (Details) [Line Items]
Percentage of public warrant	50.00%
Series of Individually Immaterial Business Acquisitions [Member] \| Over-Allotment Option [Member]
Commitments and Contingencies (Details) [Line Items]
Underwriting commissions (in Dollars)	$ 17,150,000
Percentage of gross proceeds	4.00%

Stockholders’ Deficit (Details) - $ / shares	6 Months Ended	12 Months Ended
Stockholders’ Deficit (Details) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Stockholders’ Deficit (Details) [Line Items]
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares outstanding
Preferred stock, shares issued
Converted basis percentage	25.00%
Share purchase	1
Warrant expiry, term	5 years
Redemption of warrant, description	Redemption of Warrants. Once the warrants become exercisable, the Company may redeem the outstanding warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period; and ● if, and only if, the last sale price of the Class A common stock (or the closing bid price of the Class A common stock in the event the shares of Class A common stock are not traded on any specific trading day) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and the like) for any 20 trading days within a 30 trading day period ending on the third trading day before the Company sends the notice of redemption to the warrant holders.
Public Warrants [Member]
Stockholders’ Deficit (Details) [Line Items]
Public warrants	20,125,000	20,125,000
Private Placement [Member]
Stockholders’ Deficit (Details) [Line Items]
Private placement warrants outstanding	889,375	889,375
Class A Common Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock, shares authorized	90,000,000	90,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares outstanding	1,778,750	1,778,750
Common stock, shares issued	1,778,750	1,778,750
Shares subject to possible redemption	40,250,000	40,250,000
Common stock per share (in Dollars per share)	$ 11.5
Class B Common Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock, shares authorized	20,000,000	20,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares outstanding	14,009,583	14,009,583
Common stock, shares issued	14,009,583	14,009,583
Business Combination [Member]
Stockholders’ Deficit (Details) [Line Items]
Business combination, description	(i) with respect to 25% of such shares, until consummation of the initial Business Combination, (ii) with respect to 25% of such shares, until the closing price of the Class A common stock exceeds $12.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, (iii) with respect to 25% of such shares, until the closing price of the Class A common stock exceeds $13.50 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, and (iv) with respect to 25% of such shares, until the closing price of the Class A common stock exceeds $15.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination or earlier, in any case, if, following a Business Combination, the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property. Any permitted transferees would be subject to the same restrictions and other agreements of the initial stockholders with respect to any Founder Shares.
Business Combination [Member] \| Class A Common Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
Business combination description	In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

Fair Value Measurements (Details) - Schedule of Fair Value Hierarchy of the Valuation Inputs - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Assets:
Marketable securities held in Trust Account	$ 420,376,676	$ 413,569,723
Quoted Prices In Active Markets (Level 1) [Member]
Assets:
Marketable securities held in Trust Account	420,376,676	413,569,723
Significant Other Observable Inputs (Level 2) [Member]
Assets:
Marketable securities held in Trust Account
Significant Other Unobservable Inputs (Level 3) [Member]
Assets:
Marketable securities held in Trust Account

FTAC Zeus Acquisition (NASDAQ:ZINGU)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more FTAC Zeus Acquisition Charts.

FTAC Zeus Acquisition (NASDAQ:ZINGU)
Historical Stock Chart
From Dec 2023 to Dec 2024

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

ZINGU FTAC Zeus Acquisition Corporation

FTAC Zeus Acquisition Corporation News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

ZINGU FTAC Zeus Acquisition Corporation

FTAC Zeus Acquisition Corporation News

Your Recent History

Company

Business

Popular

Get The App